The factor VIII acute phase response requires the participation of NFκB and C/EBP

Thrombosis and Haemostasis

Volumn 84, Issue 2, 2000, Pages 216-222

  Begbie, Megan ^a,b   Notley, Colleen ^a   Tinlin, Shawn ^a   Sawyer, Lisa ^a   Lillicrap, David ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Acute phase; C EBP; Factor VIII; Inflammation; NF B

Indexed keywords

ACUTE PHASE PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; BINDING PROTEIN; BLOOD CLOTTING FACTOR 8; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; TRANSCRIPTION FACTOR;

ACUTE PHASE RESPONSE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; GENE DELETION; HUMAN; HUMAN CELL; INFLAMMATION; LIVER CELL CULTURE; PRIORITY JOURNAL; PROMOTER REGION; STRESS;

EID: 0033862227     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613999     Document Type: Article

References (37)

1. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-54.
2. Umek RM, Friedman AD, McKnight SL. CCAAT-enhancer binding protein: a component of a differentiation switch. Science 1991; 251: 288-92.
3. Molitor JA, Walker WH, Doerre S, Ballard DW, Greene W. NF-kappa B: a family of inducible and differentially expressed enhancer-binding proteins in human T cells. Proc Natl Acad Sci USA 1990; 87: 10028-32.
4. Akira S, Nishio Y, Inoue M, Wang XJ, Wei S, Matsusaka T, Yoshida K, Sudo T, Naruto M. Kishimoto T. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 1994; 77: 63-71.
5. Hawkey CJ, Stirling Y, Chakrabarti R, Brozovic M, Cox AG, Meade TW. Haemostatic changes following surgery. Thromb Res 1983; 32: 223-7.
6. Rennie JA, Ogston D. Changes in coagulation factor following acute myocardial infarction in man. Haemostasis 1976; 5: 258-64.
7. Vaziri ND, Branson HE, Ness R. Changes of coagulation factors IX, VIII, VII, X, and V in nephrotic syndrome. Am J Med Sci 1980; 280: 167-71.
8. Wyshock EG. Suffredini AF, Parrillo JE, Colman RW. Cofactors V and VIII after endotoxin administration to human volunteers. Thromb Res 1995; 5: 377-89.
9. Stirling D, Hannant WA, Ludlum CA. Transcriptional activation of the Factor VIII gene in liver cell lines by interleukin-6. Thromb Haemost 1997; 79: 74-8.
10. Gorog DA, Rakhit R, Laffan M, Davies GJ. Raised Factor VIII is associated with coronary thrombotic events. Heart 1998; 80: 415-7.
11. O'Donnell J, Tuddenham EGD, Manning R. Kemball-Cook G, Johnson D, Laffan M. High prevalence of elevated Factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction. Thromb Haemost 1997; 77: 825-8.
12. Koster T, Blann AD, Briët E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995; 345: 152-5.
13. Kraaijenhagen RA, in't Anker PS, Koopman MM, Reitsma PH, Prins MH, van den Ende A, Buller HR. High plasma concentration of factor VIIIc is a major risk factor for venous thomboembolism. Thromb Haemost 2000; 83: 5-9.
14. O'Donnell J, Mumford AD, Manning RA, Laffan M. Elevation of FVIII:C in venous thrombocmbolism is persistent and independent of the acute phase response. Thromb, Haemost 2000; 83: 10-3.
15. Rosendaal FR. High levels of factor VIII and venous thrombosis. Thromb Haemost 2000; 83: 1-2.
16. Kawasaki T, Kaida T, Arnout J, Vermylen J, Hoylaerts MF. A new animal model of thrombophilia confirms that high plasma factor VIII levels are thrombogenic. Thromb Haemost 1999; 81: 306-11.
17. McGlynn LK, Mueller CR, Begbie M, Notley CR, Lillicrap DP. Role of the liver-enriched transcription factor hepatocyte nuclear factor-1 in transcriptional regulation of the factor VIII gene. Mol Cell Biol 1996; 16: 1936-45.
18. Zhang D, Jiang S-L, Rzewnicki D, Samols D, Kushner I. The effect of interleukin 1 on C-reactive protein expression in Hep3B cells is exerted at the transcriptional level. Biochem 1995; 310: 143-8.
19. von Clauss A. Gerinnungphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237-46.
20. Maire P, Wuarin J, Schibler U. The role of cis-acting promoter elements in tissue-specific albumin gene expression. Science 1989; 244: 343-6.
21. Gutierrez-Ruiz MC, Quiroz SC, Souza V, Bucio L, Hernandez E, Olivares IP, Llorente L, Vargas-Vorackova F, Kershenobich D. Cytokines, growth factors, and oxidative stress in HepG2 cells treated with ethanol, acetaldehyde, and LPS. Toxicology 1999; 134: 197-207.
22. Figueiredo MS, Brownlee GG. cis-acting elements and transcription factors involved in the promoter activity of the human Factor VIII gene. J Biol Chem 1995; 270: 11828-38.
23. Dalmon J, Laurent M, Cortois G. The human beta fibrinogen promoter contains a hepatocyte nuclear factor I-dependent interleukin-6-responsive element. Mol Cell Biol 1993; 13: 1183-93.
24. Lindhorst E, Young D, Bagshaw W, Hyland M, Kisilevskys R. Acute inflammation, acute phase serum amyloid A and cholesterol metabolism in the mouse. Biochim Biophys Acta 1997; 1339: 143-54.
25. Prasse KW, Topper MJ, Moore JN, Welles EG. Analysis of nemostasis in horses with colic. J Am Vet Med Assoc 1993; 203: 685-93.
26. Topper MJ, Prasse KW. Analysis of coagulation proteins as acute-phase reactants in horses with colic. Am J Vet Res 1998; 59: 542-5.
27. Gitschier J, Wood WJ, Goralka TM, Wion KL, Chen EY. Eaton DH, Vehar GA, Capon DJ, Lawn RM. Characterisation of the human Factor VIII gene. Nature 1984; 312: 326-30.
28. Cameron C, Notley C, Hoyle S, McGlynn L, Hough C, Kamisue S, Giles A, Lillicrap D. The canine Factor VIII cDNA and 5′ flanking sequence. Thromb Haemost 1998; 79: 317-22.
29. Healey JF, Lubin IM, Lollar P. The cDNA and derived amino acid sequence of porcine factor VIII. Blood 1996; 88: 4209-14.
30. Elder B, Lakich D. Gitschier J. Sequence of the murine factor VIII cDNA. Genomics 1993; 16: 374-9.
31. Stein B, Cogswell PC, Baldwin AS, Jr. Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction. Mol Cell Biol 1993; 13: 3964-74.
32. Wion KL, Kelly D, Summerfield JA, Tuddenham EGD, Lawn RM. Distribution of Factor VIII mRNA and antigen in human liver and other tissues. Nature 1985; 317: 726-8.
33. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV, Ignatieva EV, Ananko EA, Podkolodny OA, Kolpakov FA, Podkolodny NL, Kolchanov NA. Databases on transcriptional regulation: TRANSFAC, TRRD, and COMPEL. Nucleic Acids Res 1998; 26: 364-70.
34. Stein B, Baldwin AS, Jr. Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B. Mol Cell Biol 1993; 13: 7191-8.
35. Ray A, Hannink M, Ray BK. Concerted participation of NFkappaB and C/EBP heteromer in lipopolysaccharide induction of scrum amyloid A gene expression in liver. J Biol Chem 1995; 270: 7365-74.
36. Betts JC, Cheshire JK, Akira S, Kishimoto T, Woo P. The role of NF-kappa B and NF-IL6 transactivating factors in the synergistic activation of human serum amyloid A gene expression by interleukin-1 and interleukin-6. J Biol Chem 1993: 268: 25624-31.
37. Rosendaal FR, Briët E, Stibbe J, van Herpen G, Leuven JA, Hofman A, Vandenbroucke JP. Haemophilia protects against ischaemic heart disease: a study of risk factors. Brit J Haematol 1990; 75: 525-30.